Free Trial

Profound Medical (PROF) Competitors

Profound Medical logo
$4.52 +0.01 (+0.22%)
Closing price 04:00 PM Eastern
Extended Trading
$4.57 +0.05 (+1.11%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PROF vs. SMLR, KIDS, CBLL, TMCI, DCTH, BFLY, RXST, SNWV, CLPT, and NPCE

Should you be buying Profound Medical stock or one of its competitors? The main competitors of Profound Medical include Semler Scientific (SMLR), OrthoPediatrics (KIDS), CeriBell (CBLL), Treace Medical Concepts (TMCI), Delcath Systems (DCTH), Butterfly Network (BFLY), RxSight (RXST), Sanuwave Health (SNWV), ClearPoint Neuro (CLPT), and NeuroPace (NPCE). These companies are all part of the "medical equipment" industry.

Profound Medical vs. Its Competitors

Semler Scientific (NASDAQ:SMLR) and Profound Medical (NASDAQ:PROF) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

Semler Scientific presently has a consensus price target of $81.75, suggesting a potential upside of 167.51%. Profound Medical has a consensus price target of $11.00, suggesting a potential upside of 143.36%. Given Semler Scientific's stronger consensus rating and higher probable upside, equities analysts plainly believe Semler Scientific is more favorable than Profound Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Semler Scientific
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25
Profound Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

49.4% of Semler Scientific shares are held by institutional investors. Comparatively, 47.9% of Profound Medical shares are held by institutional investors. 16.4% of Semler Scientific shares are held by insiders. Comparatively, 1.5% of Profound Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Semler Scientific has a beta of 1.34, indicating that its stock price is 34% more volatile than the S&P 500. Comparatively, Profound Medical has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500.

Semler Scientific has a net margin of 86.20% compared to Profound Medical's net margin of -343.97%. Semler Scientific's return on equity of 43.84% beat Profound Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Semler Scientific86.20% 43.84% 32.88%
Profound Medical -343.97%-89.74%-73.06%

In the previous week, Semler Scientific had 2 more articles in the media than Profound Medical. MarketBeat recorded 4 mentions for Semler Scientific and 2 mentions for Profound Medical. Semler Scientific's average media sentiment score of 1.76 beat Profound Medical's score of 1.21 indicating that Semler Scientific is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Semler Scientific
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Profound Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Semler Scientific has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Semler Scientific$56.29M8.04$40.90M$2.4312.58
Profound Medical$10.68M12.72-$27.82M-$1.46-3.10

Summary

Semler Scientific beats Profound Medical on 16 of the 17 factors compared between the two stocks.

Get Profound Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PROF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PROF vs. The Competition

MetricProfound MedicalMED IndustryMedical SectorNASDAQ Exchange
Market Cap$135.83M$2.48B$5.74B$9.78B
Dividend YieldN/A1.67%4.40%4.04%
P/E Ratio-3.1022.5330.8326.39
Price / Sales12.72506.55382.9086.63
Price / CashN/A178.3537.7259.11
Price / Book3.456.2910.106.62
Net Income-$27.82M$32.94M$3.26B$265.42M
7 Day Performance-2.59%2.27%3.90%3.58%
1 Month Performance-20.42%1.06%3.73%0.46%
1 Year Performance-49.89%5.65%37.68%19.41%

Profound Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PROF
Profound Medical
1.8324 of 5 stars
$4.52
+0.2%
$11.00
+143.4%
-51.0%$135.83M$10.68M-3.10150Gap Down
SMLR
Semler Scientific
3.4531 of 5 stars
$33.76
-0.2%
$81.75
+142.2%
+5.1%$500.99M$56.29M13.89120News Coverage
KIDS
OrthoPediatrics
4.4061 of 5 stars
$19.20
+0.1%
$34.14
+77.8%
-30.5%$481.16M$204.73M-10.73200Positive News
CBLL
CeriBell
2.2549 of 5 stars
$12.18
-1.1%
$32.14
+163.9%
N/A$451.33M$65.44M-4.07N/A
TMCI
Treace Medical Concepts
2.4238 of 5 stars
$7.04
+2.2%
$9.83
+39.7%
+18.5%$435.26M$209.36M-8.91250
DCTH
Delcath Systems
2.5781 of 5 stars
$10.65
+2.8%
$24.50
+130.0%
+21.9%$362.41M$37.21M213.0060
BFLY
Butterfly Network
2.8203 of 5 stars
$1.44
+0.7%
$3.00
+108.3%
+60.1%$359.99M$82.06M-5.14460Gap Up
RXST
RxSight
1.6275 of 5 stars
$8.49
+0.7%
$10.00
+17.8%
-84.8%$344.92M$139.93M-10.61220
SNWV
Sanuwave Health
2.2877 of 5 stars
$38.36
-0.6%
$49.00
+27.7%
N/A$330.81M$32.63M-4.6540
CLPT
ClearPoint Neuro
2.095 of 5 stars
$11.22
-2.9%
$19.67
+75.3%
-9.1%$328.34M$31.39M-13.85110Positive News
NPCE
NeuroPace
3.0042 of 5 stars
$8.42
-1.6%
$16.60
+97.1%
+10.2%$283.18M$79.91M-10.02170

Related Companies and Tools


This page (NASDAQ:PROF) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners